Pharmacist Continuing Education

Sponsored by Dannemiller

Faculty
John Kriak, PharmD
President and Chief Consultant, CAMMCO, LLC

Statement of Need
The field of pain management is challenging and should be multidimensional in both assessment and treatment with a predilection for various approaches utilizing pharmacotherapy. Pharmacotherapy, however, is fraught with its own challenges and impediments. Breakthrough pain, for example, is a frequent problem that occurs in the presence of otherwise stable, persistent pain and may be a predictor of poor response to treatment with routine pharmacotherapy. In addition, elderly patients are at a significantly higher risk of adverse drug reactions and overdosing to pharmacologic intervention because of pharmacokinetic and metabolic changes associated with age. In accordance with the challenging needs and obstacles pervasive in the professions associated with pain management, it is critical to update these professionals on the latest research regarding the challenging categories of pain and their treatment. This program will empower pharmacists and physicians to better identify effective treatments which are likely to cause the fewest side effects by exploring the underlying pathophysiology of various types of pain and the effects of various pharmacological agents.

Objectives
Each CME/CE module contains learning objectives. These objectives are listed at the beginning of each module.

Intended Audience
This CME/CE activity is intended for practicing pharmacists and physicians who have an interest in pain management.

Pharmacists
Dannemiller is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is a practice based activity. Dannemiller has assigned 1.0 contact hours (0.1 CEU) of continuing pharmacy education credit to this activity. ACPE program number 522-000-11-002-H01-P.

Accreditation Statement
Dannemiller is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians
Dannemiller designates this educational activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Method of Participation
This activity should take approximately one hour to complete. Participants should first read the objectives and other introductory CE information, and then proceed to the educational offering. After completing an activity, participants may choose to complete the posttest toward the award of a certificate for credit. This credit is valid through February 24, 2013. No credit will be given after this date.

In the event you are unable to print the certificate, please e-mail editor@dannemiller.com and a certificate will be mailed within 2 weeks.

System requirements

• Computer or smart phone with internet access
• Adobe Flash Player, Web Browser (IE 7.0+ or Webkit/Mozilla Compatible) with JavaScript enabled.

Disclosures
In accordance with the Accreditation Council for Continuing Medical Education (ACCME), Dannemiller requires that any person who is in a position to control the content of a CME activity must disclose all financial relationships they have with a commercial interest. Dr. John Kriak reports nothing to disclose.

Dannemiller staff and all others involved in the development of this activity have no relationships with commercial interests. To resolve identified conflicts of interest, the educational content was fully reviewed by a physician member of the Dannemiller Clinical Content Review Committee who has nothing to disclose. The resulting certified activity was found to provide educational content that is current, evidence based and commercially balanced.

Off-label Statement
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicted by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Disclaimer
The contents and views presented in this educational activity are those of the authors and do not necessarily reflect those of Dannemiller. This material is prepared based upon a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials on the subject matter before relying solely upon the information contained within this educational activity.

For questions regarding the content of this activity and technical assistance, contact Dannemiller, accredited provider for this CME activity, at editor@dannemiller.com.